|
taurine
|
CHEBI_15891 |
[An amino sulfonic acid that is the 2-amino derivative of ethanesulfonic acid. It is a naturally occurring amino acid derived from methionine and cysteine metabolism. An abundant component of fish- and meat-based foods, it has been used as an oral supplement in the treatment of disorders such as cystic fibrosis and hypertension.] |
|
RIPK2
|
OGG_3000008767 |
|
|
VLDLR
|
OGG_3000007436 |
|
|
Comparative Study
|
SCDO_0000268 |
[Comparison of outcomes, results, responses, etc for different techniques, therapeutic approaches or other inputs.] |
|
(R)-5-diphosphomevalonic acid
|
CHEBI_15899 |
[The 5-diphospho derivative of (R)-mevalonic acid.] |
|
phosphorus oxoacids and derivatives
|
CHEBI_36360 |
|
|
oxoacid derivative
|
CHEBI_33241 |
|
|
cilazapril
|
CHEBI_3698 |
[A pyridazinodiazepine resulting from the formal condensation of the carboxy group of cilazaprilat with ethanol. It is a drug used in the treatment of hypertension and heart failure.] |
|
Alzheimer disease 6
|
MONDO_0011561 |
[An Alzheimer's disease that is characterized by an associated with variation in the region 10q24.] |
|
catechin
|
CHEBI_23053 |
[Members of the class of hydroxyflavan that have a flavan-3-ol skeleton and its substituted derivatives.] |
|
indometacin
|
CHEBI_49662 |
[A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.] |
|
ribose phosphate
|
CHEBI_26562 |
|
|
CALM2
|
OGG_3000000805 |
|
|
cortex
|
UBERON_0001851 |
[Outermost layer of an organ[WP].] |
|
CALM1
|
OGG_3000000801 |
|
|
imipramine
|
CHEBI_47499 |
[A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.] |
|
rosuvastatin
|
CHEBI_38545 |
[A dihydroxy monocarboxylic acid that is (6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl} hept-6-enoic acid carrying two hydroxy substituents at positions 3 and 5 (the 3R,5S-diastereomer).] |
|
FADD
|
OGG_3000008772 |
|
|
Metabolic Marker
|
NCIT_C18520 |
[Specific metabolic changes that characterize an organism's state of health or disease, or response to a particular therapeutic intervention, and helps make diagnosis more accurate or enable physicians to make diagnosis before symptoms appear and to track disease progression.] |
|
WNT3A
|
OGG_3000089780 |
|
